DexCom, Inc. - Common Stock (NQ:DXCM)

ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

August 24, 2024

From The Rosen Law Firm PA

DXCM Investor Alert: Robbins LLP Reminds DexCom Inc. Shareholders of the Securities Class Action Lawsuit

August 23, 2024

From Robbins LLP

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)

Decoding 18 Analyst Evaluations For DexCom ↗

August 23, 2024

Via Benzinga

August 23, 2024

From Law Offices of Howard G. Smith

NASDAQ: DXCM: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against DexCom, Inc.

August 23, 2024

From Kessler Topaz Meltzer & Check, LLP

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. (DXCM) Investors

August 22, 2024

From Glancy Prongay & Murray LLP

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. (DXCM) Investors

August 22, 2024

From Law Offices of Howard G. Smith

DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT: Investors With Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

August 22, 2024

From Bernstein Liebhard LLP

Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

August 22, 2024

From The Rosen Law Firm, P.A.

DXCM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That DexCom, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

August 22, 2024

From Robbins Geller Rudman & Dowd LLP

DEXCOM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DexCom, Inc. and Encourages Investors to Contact the Firm

August 21, 2024

From Bragar Eagel & Squire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

August 21, 2024

From The Schall Law Firm

Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against DexCom Inc.

August 21, 2024

From Robbins LLP

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom

August 21, 2024

From Faruqi & Faruqi LLP

These stocks took a dive recently, and that could spell opportunity.

Is It Time to Buy July's Worst-Performing S&P 500 Stocks? ↗

August 21, 2024

S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday? ↗

Topics Stocks

August 20, 2024

S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest.

Via Benzinga

Topics Stocks

S&P 500, Nasdaq Look To Snap Best Win Streaks Of 2024 ↗

August 20, 2024

Stocks are taking a breather, with the S&P 500 Index and Nasdaq Composite Index firmly lower this afternoon after yesterday nabbing their eighth-straight gains and best win streaks of the year.

Via Talk Markets

Topics Stocks

Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Iris Energy, and DexCom and Encourages Investors to Contact the Firm

August 19, 2024

From Bragar Eagel & Squire

S&P 500, Nasdaq 100 Extend 8-Session Winning Streak As Wall Street Jitters 'Go Poof': Monday's Key Stock Movers ↗

August 19, 2024

Via Benzinga

Topics Stocks

2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200 ↗

August 18, 2024

These companies' growth paths should only be briefly interrupted by headwinds.

Look beyond share price at the business behind the stock, and you might find there's more for investors to consider.

2 Growth Stocks to Buy at a Discount ↗

August 18, 2024

Over the past twelve months, 10 large-cap stocks have underperformed all others. Here’s this week’s list of the top 10 worst performing large-caps.

Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers ↗

August 17, 2024

Via Talk Markets

S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers ↗

August 16, 2024

S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positive economic data. SPY and QQQ close with modest daily gains while DIA has best...

Via Benzinga

Topics Stocks

1 Growth Stock Down 43% to Buy Right Now ↗

August 16, 2024

Here's why DexCom should be on your radar after the company's share price plunged recently.

Three stocks have stood out for call option traders to bet on in the coming months as a view for a recovery rally after an S&P 500 sell-off last week

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 15, 2024

Via Benzinga

Top 3 Stocks to Watch: Options Traders Bet on Big Gains

August 13, 2024

Via MarketBeat

Topics Stocks

Should You Buy the 3 Worst Nasdaq 100 Stocks Since the Tech Sector Selloff? ↗

August 12, 2024

The tech sector began selling off in July as investors abandoned former higher fliers, leaving these three as the worst Nasdaq 100 stocks.

Via InvestorPlace

DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 09, 2024

From Bronstein, Gewirtz & Grossman, LLC

DexCom now trades at a drastically lower earnings multiple than it has in the past.

Should You Buy DexCom Stock After Its Post-Earnings Sell-Off? ↗

August 08, 2024